City

Bethesda (1)

Condition

Neuroendocrine Tumors (1)

VHL Pancreatic Neuroendocrine Tumors (1)

Von Hippel-Lindau Disease (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

National Cancer Institute (NCI) (1)

Collaborator

Intervention

68-gallium dotatate (1)

Study Documents

Intervention Type

drug (1)

Funder Type

NIH (1)

Study Type

Interventional (1)

vhl pancreatic neuroendocrine tumors

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

VHL Pancreatic Neuroendocrine Tumors, Von Hippel-Lindau Disease, Neuroendocrine Tumors Trial run by the National Cancer

Recruiting

VHL Pancreatic Neuroendocrine Tumors
+2 more

68-Gallium DOTATATE

Bethesda, Maryland

National Institutes of Health Clinical Center

Jan 26, 2023